X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (332) 332
index medicus (243) 243
hiv (238) 238
male (216) 216
infectious diseases (211) 211
female (206) 206
hiv infections - complications (204) 204
hiv/hcv coinfection (188) 188
adult (186) 186
middle aged (168) 168
human-immunodeficiency-virus (156) 156
hepatitis c (154) 154
hiv infections - drug therapy (154) 154
hepatitis c virus (145) 145
antiviral agents - therapeutic use (124) 124
antiretroviral therapy (102) 102
coinfection (102) 102
hepatitis c - complications (102) 102
hepatitis c, chronic - drug therapy (89) 89
hepatitis c - drug therapy (87) 87
immunology (87) 87
virus diseases (84) 84
hepatitis c, chronic - complications (82) 82
virology (79) 79
gastroenterology & hepatology (78) 78
hcv (78) 78
hiv infection (77) 77
liver fibrosis (76) 76
hepatitis (74) 74
hepacivirus - genetics (72) 72
health aspects (70) 70
comorbidity (68) 68
hiv infections - virology (68) 68
genotype (67) 67
human immunodeficiency virus--hiv (67) 67
infected patients (67) 67
treatment outcome (65) 65
risk factors (64) 64
ribavirin - therapeutic use (63) 63
antiviral agents (62) 62
viral load (62) 62
chronic hepatitis-c (60) 60
hepatitis-c virus (60) 60
interferon-alpha - therapeutic use (58) 58
drug therapy, combination (57) 57
hepatitis c - virology (55) 55
ribavirin (55) 55
fibrosis (54) 54
infection (54) 54
coinfection - drug therapy (53) 53
liver (53) 53
microbiology (53) 53
sustained virological response (53) 53
hiv infections - epidemiology (51) 51
hiv patients (51) 51
prevalence (51) 51
care and treatment (50) 50
hcv coinfection (50) 50
mortality (50) 50
hiv-hcv coinfection (49) 49
analysis (48) 48
hepatitis c - epidemiology (48) 48
hiv/hcv co-infection (48) 48
retrospective studies (48) 48
therapy (47) 47
cirrhosis (45) 45
hiv-infected patients (44) 44
cohort studies (43) 43
antiviral agents - adverse effects (40) 40
drug therapy (40) 40
hiv/hcv-coinfected patients (40) 40
pharmacology & pharmacy (40) 40
research (40) 40
antiretroviral therapy, highly active (39) 39
disease (39) 39
disease progression (39) 39
highly active antiretroviral therapy (39) 39
interferon (39) 39
alpha-2a plus ribavirin (38) 38
cd4 lymphocyte count (38) 38
hepatitis c, chronic - virology (38) 38
antiviral agents - administration & dosage (37) 37
coinfection - virology (37) 37
hiv infections - immunology (37) 37
liver diseases (37) 37
polyethylene glycols - therapeutic use (37) 37
hiv/hcv (36) 36
aged (35) 35
progression (35) 35
ribavirin - administration & dosage (35) 35
active antiretroviral therapy (34) 34
risk-factors (33) 33
transient elastography (32) 32
prospective studies (31) 31
rna, viral - blood (31) 31
aids/hiv (30) 30
hepacivirus - drug effects (30) 30
infections (30) 30
natural-history (30) 30
patients (30) 30
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (440) 440
Spanish (7) 7
French (6) 6
Japanese (3) 3
German (2) 2
Italian (2) 2
Portuguese (2) 2
Russian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 07/2008, Volume 23, Issue 7pt1, pp. 1000 - 1008
The significant burden of HIV/hepatitis C virus (HCV) coinfection is increasingly recognized worldwide, and in particular within the Asia–Pacific region.... 
HIV | Hepatitis C | Pegylated interferon | Antiretroviral therapy | Natural history | MITOCHONDRIAL TOXICITY | RISK-FACTORS | antiretroviral therapy | hepatitis C | pegylated interferon | INJECTING DRUG-USERS | HUMAN-IMMUNODEFICIENCY-VIRUS | natural history | HIV/HCV COINFECTION | SUSTAINED VIROLOGICAL RESPONSE | ACTIVE ANTIRETROVIRAL THERAPY | ALPHA-2A PLUS RIBAVIRIN | INFECTED PATIENTS | STAGE LIVER-DISEASE | GASTROENTEROLOGY & HEPATOLOGY | Liver - virology | Prevalence | Hepatitis C - drug therapy | Liver Failure - drug therapy | Hepacivirus - immunology | HIV Infections - epidemiology | Humans | Hepacivirus - genetics | RNA, Viral - blood | Viral Load | Liver Failure - virology | HIV Infections - immunology | Hepatitis C - immunology | Drug Interactions | Liver - drug effects | Hepatitis C Antibodies - blood | HIV Infections - diagnosis | Hepatitis C - epidemiology | Anti-HIV Agents - therapeutic use | Hepatitis C - complications | Antiviral Agents - therapeutic use | Anti-HIV Agents - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Disease Progression | Antiretroviral Therapy, Highly Active | Hepatitis C - diagnosis | Antiviral Agents - adverse effects | HIV Infections - complications | HIV Infections - drug therapy | Hepatitis C, epidemiology | Hepacivirus, immunology | Hepatitis C, complications | Hepatitis C, immunology | HIV Infections, immunology | Liver Failure, virology | HIV Infections, diagnosis | Liver, virology | Antiviral Agents, adverse effects | Hepatitis C, diagnosis | HIV Infections, epidemiology | Hepacivirus, genetics | HIV Infections, complications | Hepatitis C Antibodies, blood | Antiviral Agents, therapeutic use | Anti-HIV Agents, adverse effects | RNA, Viral, blood | Anti-HIV Agents, therapeutic use | Liver Failure, drug therapy | HIV Infections, drug therapy | Hepatitis C, drug therapy | Liver, drug effects | Highly active antiretroviral therapy | Biological response modifiers | HIV (Viruses) | Comorbidity | Index Medicus
Journal Article
Journal Article
JOURNAL OF INFECTIOUS DISEASES, ISSN 0022-1899, 07/2016, Volume 214, Issue 1, pp. 80 - 86
Background. Liver fibrosis progresses faster in individuals coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Interferon.3... 
CLEARANCE | INFECTIOUS DISEASES | MICROBIOLOGY | HIV-HCV co-infection | IMMUNOLOGY | liver fibrosis | THERAPY | IL28B GENOTYPE | DISEASE | GENES | IFNL | INFECTION | HCV | COHORT | PROGRESSION | SEVERITY
Journal Article
Antiviral Therapy, ISSN 1359-6535, 2017, Volume 22, Issue 3, pp. 225 - 236
Background: HIV-HCV-coinfected patients respond just as well to modern direct-acting antiviral HCV therapy as HCV-monoinfected patients. However, clinical data... 
PSI-7977 | INFECTIOUS DISEASES | HIV/HCV | IMPAIRMENT | VIROLOGY | HEPATITIS-C VIRUS | PHARMACOKINETICS | METHADONE | BUPRENORPHINE | PHARMACOLOGY & PHARMACY | INFECTION | PEOPLE | INHIBITOR
Journal Article